1. Home
  2. PHX vs ACTU Comparison

PHX vs ACTU Comparison

Compare PHX & ACTU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHX
  • ACTU
  • Stock Information
  • Founded
  • PHX 1926
  • ACTU 2015
  • Country
  • PHX United States
  • ACTU United States
  • Employees
  • PHX N/A
  • ACTU N/A
  • Industry
  • PHX Oil & Gas Production
  • ACTU
  • Sector
  • PHX Energy
  • ACTU
  • Exchange
  • PHX Nasdaq
  • ACTU NYSE
  • Market Cap
  • PHX 137.2M
  • ACTU 153.1M
  • IPO Year
  • PHX N/A
  • ACTU 2024
  • Fundamental
  • Price
  • PHX $3.78
  • ACTU $6.74
  • Analyst Decision
  • PHX Strong Buy
  • ACTU
  • Analyst Count
  • PHX 2
  • ACTU 0
  • Target Price
  • PHX $4.90
  • ACTU N/A
  • AVG Volume (30 Days)
  • PHX 100.0K
  • ACTU 73.4K
  • Earning Date
  • PHX 11-06-2024
  • ACTU 11-13-2024
  • Dividend Yield
  • PHX 4.22%
  • ACTU N/A
  • EPS Growth
  • PHX N/A
  • ACTU N/A
  • EPS
  • PHX 0.13
  • ACTU N/A
  • Revenue
  • PHX $31,939,771.00
  • ACTU N/A
  • Revenue This Year
  • PHX $6.31
  • ACTU N/A
  • Revenue Next Year
  • PHX $22.61
  • ACTU N/A
  • P/E Ratio
  • PHX $29.06
  • ACTU N/A
  • Revenue Growth
  • PHX N/A
  • ACTU N/A
  • 52 Week Low
  • PHX $2.95
  • ACTU $5.51
  • 52 Week High
  • PHX $4.08
  • ACTU $10.16
  • Technical
  • Relative Strength Index (RSI)
  • PHX 49.13
  • ACTU N/A
  • Support Level
  • PHX $3.71
  • ACTU N/A
  • Resistance Level
  • PHX $3.97
  • ACTU N/A
  • Average True Range (ATR)
  • PHX 0.14
  • ACTU 0.00
  • MACD
  • PHX -0.02
  • ACTU 0.00
  • Stochastic Oscillator
  • PHX 18.92
  • ACTU 0.00

About PHX PHX Minerals Inc.

PHX Minerals Inc is an oil and natural gas mineral company that has employed a plan to shift the core of its business away from drilling and toward perpetual mineral and natural gas ownership. The company owns substantial mineral acreage, principally in Oklahoma, North Dakota, Texas, New Mexico, and Arkansas, but still maintains legacy interests in natural gas and oil properties that have retired operations. The revenues is derived from royalties granted from the production and sale of natural gas, oil and NGL, and the remaining portion of its revenues is derived from the production and sale of natural gas, oil and NGL on its working interests.

About ACTU ACTUATE THERAPEUTICS INC

Actuate Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). It is developing elraglusib (formerly 9-ING-41), a small molecule that is designed to enter cancer cells and block the function of the enzyme GSK-3β, a master regulator of complex biological signaling cascades, including those mediated by oncogenes, that lead to tumor cell survival, growth, migration, and invasion.

Share on Social Networks: